This topic contains a solution. Click here to go to the answer

Author Question: Pantothenic acid remains stable during food processing. Indicate whether the statement is true or ... (Read 84 times)

genevieve1028

  • Hero Member
  • *****
  • Posts: 601
Pantothenic acid remains stable during food processing.
  Indicate whether the statement is true or false

Question 2

Describe how glycated hemoglobin is used to evaluate long-term glycemic control.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

al

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

False

Answer to Question 2

The glucose in blood freely enters red blood cells and attaches to hemoglobin in direct proportion to the amount of glucose present. The percentage of HbA1c reflects glycemic control over the preceding 2 to 3 months, the average age of circulating red blood cells. The goal of diabetes treatment is usually an HbA1c value less than 7 percent. Less stringent HbA1c goals (for example, an HbA1c value less than 8 percent) may be suitable for some patients, including those with limited life expectancy, advanced diabetic complications, or a history of severe hypoglycemia. HbA1c testing is typically conducted two to four times yearly





 

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library